EUVIMEDEUVIMED entdecken
Crossref

Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease

Sadegh Moradi Vastegani, Seyed Esmaeil Khoshnam, Esrafil Mansouri, Somayeh Hajipour, Samireh Ghafouri, Nima Bakhtiari, Alireza Sarkaki, Yaghoob Farbood

Behavioural Brain Research · 2023-02 · 437 · 114100

DOI: 10.1016/j.bbr.2022.114100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2023-02. Verfasst von Sadegh Moradi Vastegani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Neuroprotective Agents, Parkinson Disease. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Ahvaz Jundishapur University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Non-motor symptoms (NMS) have high prevalence in patients with Parkinson's disease (PD). These symptoms are mainly the result of increased oxidative stress and neuronal damage. In this study we investigated the possible neuroprotective effects of anethole as a potent antioxidant on rotenone-induced behavioral deficits, hippocampal neuronal death, and oxidative stress profile in rats. METHODS: Male Wistar rats were administered with anethole (62.5, 125, and 250 mg/kg, i.g) concomitantly with rotenone (2 mg/kg, s.c) for 35 days. Shuttle box and novel object recognition tests were performed to determine cognitive functions, and tail flick test was used to measure pain sensitivity. The levels of BDNF, MDA, SOD, and GPx were assayed in the hippocampus. Hippocampal neuronal damage was evaluated using cresyl violet staining technique. RESULTS: Chronic administration of rotenone induced cognitive deficit and reduced thermal pain threshold. Rotenone also decreased SOD and GPx activities, increased MDA level, and reduced the expression of BDNF in the hippocampus. In addition, hippocampal neuronal loss was increased in rotenone treated rats. Treatment with high dose of anethole (250 mg/kg) improved cognitive function and increased pain threshold in all three doses (62.5, 125, and 250 mg/kg). Despite the unchanged SOD and GPx activities, hippocampal levels of MDA was significantly decreased after high-dose anethole treatment. Moreover, High dose of anethole increased the number of surviving neurons in the hippocampus, but couldn't increase the BDNF expression. CONCLUSION: Our findings indicated that anethole has antioxidant and neuroprotective effects against non-motor disorders induced by rotenone toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsParkinson DiseaseAnimalsRatsMaleRotenoneAntioxidantsBrain-Derived Neurotrophic FactorRats, WistarOxidative StressSuperoxide DismutaseDisease Models, AnimalAnisolesAllylbenzene Derivatives

Stichwörter der Autor:innen

AnetholeBDNFHippocampusNon-motor symptomsOxidative stressParkinson’s diseaseRotenone

Substanzen

RotenoneNeuroprotective AgentsAntioxidantsBrain-Derived Neurotrophic FactorSuperoxide DismutaseanetholeAnisolesAllylbenzene Derivatives

Autor:innen und Institutionen

  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Cellular and molecular research center, Medical Basic Sciences Research Institute, Department of Anatomical Sciences, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Department of Physiology, Medicine Faculty, Ahvaz Jundishapur University…
  • Pain Research Center, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Förderung

  • Ahvaz Jundishapur University of Medical Sciences

Zitieren

APA

Vastegani, S. M., Khoshnam, S. E., Mansouri, E., Hajipour, S., Ghafouri, S., Bakhtiari, N., Sarkaki, A., & Farbood, Y. (2023). Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease. Behavioural Brain Research, 437, 114100. https://doi.org/10.1016/j.bbr.2022.114100

Vancouver

Vastegani SM, Khoshnam SE, Mansouri E, Hajipour S, Ghafouri S, Bakhtiari N, et al. Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease. Behavioural Brain Research. 2023;437:114100. doi:10.1016/j.bbr.2022.114100

BibTeX
@article{Vastegani2023,
  author = {Vastegani, Sadegh Moradi and Khoshnam, Seyed Esmaeil and Mansouri, Esrafil and Hajipour, Somayeh and Ghafouri, Samireh and Bakhtiari, Nima and Sarkaki, Alireza and Farbood, Yaghoob},
  title = {Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson’s disease},
  journal = {Behavioural Brain Research},
  year = {2023},
  volume = {437},
  pages = {114100},
  doi = {10.1016/j.bbr.2022.114100}
}
Kostenlos starten →